Adagene Company

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.
Industry: End-to-end Drug Development
Headquarters: Suzhou, Jiangsu, China
Founded Date: 2011-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 11
Total Funding: 155000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-02-11
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership